Stockreport

Genenta Science Provides Update on CEO Ownership

Genenta Science S.p.A.  (GNTA) 
PDF MILAN and NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a clinical-stage gene-therapy company developing hematopoietic stem-cell-based im [Read more]